Response Patterns and Impact of Mrd in Patients With IDH1/2-Mutated Aml Treated With Venetoclax and Hypomethylating Agents

Authors

Danielle Hammond
Sanam Loghavi
Sa A Wang
Marina Y Konopleva
Tapan M Kadia
Naval G Daver
Maro Ohanian
Ghayas C Issa
Yesid Alvarado
Nicholas J Short
Koji Sasaki
Naveen Pemmaraju
Guillermo Montalban-Bravo
Curtis A Lachowiez
Abhishek Maiti
Guillermo Garcia-Manero
Elias J Jabbour
Gautam Borthakur
Farhad Ravandi
Koichi Takahashi
Sherry R Pierce
Hagop M Kantarjian
Courtney D DiNardo

Language

English

Publication Date

9-21-2023

Journal

Blood Cancer Journal

DOI

10.1038/s41408-023-00915-6

PMID

37735426

PMCID

PMC10514257

PubMedCentral® Posted Date

9-21-2023

PubMedCentral® Full Text Version

Post-print

Keywords

Humans, Bridged Bicyclo Compounds, Heterocyclic, Sulfonamides, Leukemia, Myeloid, Acute, Isocitrate Dehydrogenase

Published Open-Access

yes

Recommended Citation

Hammond, Danielle; Loghavi, Sanam; Wang, Sa A; et al., "Response Patterns and Impact of Mrd in Patients With IDH1/2-Mutated Aml Treated With Venetoclax and Hypomethylating Agents" (2023). Faculty, Staff and Student Publications. 5550.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/5550